首页 › 基金 › JACOBS LEVY EQUITY MANAGEMENT, INC › EW
JACOBS LEVY EQUITY MANAGEMENT, INC 对 EW 的持仓历史
EDWARDS LIFESCIENCES CORP · 医疗保健
JACOBS LEVY EQUITY MANAGEMENT, INC 在 Q2 2026 的 13F 申报中披露持有 EW(EDWARDS LIFESCIENCES CORP)2,772,232 股,市值约 US$250.8M,约占其申报组合的 0.90%,在其申报持仓中市值排名第 17 位。 JACOBS LEVY EQUITY MANAGEMENT, INC 最近 12 个申报季度中有 12 个季度披露了 EW 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
JACOBS LEVY EQUITY MANAGEMENT, INC 对 EW 的持仓演变
JACOBS LEVY EQUITY MANAGEMENT, INC 于 Q3 2023 首次披露 EW 持仓:2,244,774 股(约 US$155.5M)。 该持仓在 Q4 2024 达到峰值 4,615,163 股,市值约 US$341.7M。 在 12 次申报中,JACOBS LEVY EQUITY MANAGEMENT, INC 4 次增持、7 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 2,772,232 股、市值约 US$250.8M,环比减持 -160,564 股。。 持仓曾出现大幅变动:Q1 2024 减持约 41% (随后一个季度股价下跌 3%)、Q3 2024 增持约 240% (随后一个季度股价上涨 12%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.24M | $155.52M | 新进 |
| Q4 2023 | 2.39M | $182.52M | 增持 |
| Q1 2024 | 1.42M | $135.34M | 减持 |
| Q2 2024 | 1.09M | $100.38M | 减持 |
| Q3 2024 | 3.69M | $243.74M | 增持 |
| Q4 2024 | 4.62M | $341.66M | 增持 |
| Q1 2025 | 4.36M | $316.19M | 减持 |
| Q2 2025 | 3.44M | $269.08M | 减持 |
| Q3 2025 | 3.08M | $239.40M | 减持 |
| Q4 2025 | 3.11M | $265.54M | 增持 |
| Q1 2026 | 2.93M | $234.86M | 减持 |
| Q2 2026 | 2.77M | $250.78M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 EW 与 13F 数据
EW(EDWARDS LIFESCIENCES CORP)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 EW,申报仓位最大的包括:DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 EW 的基金
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M 股 · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M 股 · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M 股 · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M 股 · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.63M 股 · $599.36M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.80M 股 · $434.21M · Q2 2026
更多关于 JACOBS LEVY EQUITY MANAGEMENT, INC
常见问题
How long has JACOBS LEVY EQUITY MANAGEMENT, INC held EW?
JACOBS LEVY EQUITY MANAGEMENT, INC has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is JACOBS LEVY EQUITY MANAGEMENT, INC's current position in EW?
As of Q2 2026, JACOBS LEVY EQUITY MANAGEMENT, INC holds 2.77M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $250.78M, representing 0.90% of its reported portfolio and ranking #17.
Has JACOBS LEVY EQUITY MANAGEMENT, INC been buying or selling EW?
In the latest 13F filing (Q2 2026), JACOBS LEVY EQUITY MANAGEMENT, INC reduced its position in EW. The position peaked in Q4 2024 at 4.62M shares.
Which other funds hold EW?
Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.